KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Amortization of Deferred Charges (2016 - 2026)

Biomarin Pharmaceutical's Amortization of Deferred Charges history spans 14 years, with the latest figure at $653000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Amortization of Deferred Charges fell 1.06% year-over-year to $653000.0, compared with a TTM value of $1.4 million through Dec 2025, down 26.7%, and an annual FY2025 reading of $2.6 million, down 21.94% over the prior year.
  • Amortization of Deferred Charges for Q4 2025 was $653000.0 at Biomarin Pharmaceutical, up from $27000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.0 million in Q1 2021, with the low at $27000.0 in Q2 2025.
  • Average Amortization of Deferred Charges over 5 years is $513800.0, with a median of $401000.0 recorded in 2023.
  • Year-over-year, Amortization of Deferred Charges rose 0.68% in 2023 and then tumbled 81.76% in 2025.
  • Tracing BMRN's Amortization of Deferred Charges over 5 years: stood at $1.0 million in 2021, then fell by 0.39% to $1.0 million in 2022, then fell by 3.7% to $990000.0 in 2023, then tumbled by 33.33% to $660000.0 in 2024, then fell by 1.06% to $653000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Amortization of Deferred Charges are $653000.0 (Q4 2025), $27000.0 (Q3 2025), and $27000.0 (Q2 2025).